Physician profile
Amy Swan
NPI 1376314401
$622.07
in general payments reported to CMS, 2019-2025
14 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $185 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $116.05 | 2024 | |
| Pfizer INC. | $115.93 | 2024-2025 | |
| Exact Sciences Corporation | $61.12 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $55.27 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $53.25 | 2024-2025 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $50.14 | 2024-2025 | Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $49.50 | 2025 | Rexulti |
| Amgen INC. | $20.35 | 2025 | Repatha, Otezla |
| Alk-Abello, INC | $19.82 | 2025 | Grastek, Ragwitek, Odactra |
| Edwards Lifesciences Corporation | $19.26 | 2025 | |
| Abbvie INC. | $18.25 | 2025 | |
| Philips North America LLC | $15.60 | 2025 | Extended Holter |
| Astrazeneca Pharmaceuticals Lp | $13.87 | 2025 | Breztri |
| Merck Sharp & Dohme LLC | $13.66 | 2025 | Capvaxive, Vaxneuvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Swan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.